Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Aurélia Mittoux"'
Autor:
Rigmor H. Jensen, Henrik Winther Schytz, Cristina Tassorelli, Gisela M. Terwindt, Louise N. Carlsen, Aurélia Mittoux, Ole Østerberg, Richard B. Lipton, Stewart J. Tepper, Andrew Blumenfeld, Christofer Lundqvist
Publikováno v:
Frontiers in Neurology, Vol 14 (2023)
IntroductionMigraine is a highly prevalent and disabling neurological disease. Excessive use of acute medications can lead to medication-overuse headache (MOH), occurring when a patient experiences an increasing number of headache and migraine days,
Externí odkaz:
https://doaj.org/article/8522cd2252394345a8c40c52d7456c2f
Autor:
John M, Kane, Bruce J, Kinon, Carlos, Forray, Pedro, Such, Aurélia, Mittoux, Ole M, Lemming, Peter, Hertel, Oliver D, Howes
Publikováno v:
Schizophrenia Research. 248:271-278
Treatment resistance constitutes the highest burden of disease within schizophrenia. We hypothesized that the synergistic activity of Lu AF35700 at dopamine Dsub1/suband Dsub2/subreceptors might provide superior antipsychotic effects versus first-lin
Publikováno v:
Journal of Affective Disorders. 278:288-295
Background Circadian rhythm disturbances have been reported in patients with major depressive disorder (MDD). Among these is an increased phase angle between peak cortisol concentration and dim-light melatonin onset (DLMO). The aim of this study was
Autor:
Shl Thomas, Gillian C. Hall, R. D. Mann, Miriam C. J. M. Sturkenboom, Aurélia Mittoux, Marc Crocq, Mondher Toumi, C. Le Jeunne, Nicholas Moore, Malcolm Lader, Florence Thibaut, Brian Everitt, Milou Daniel Drici, Silvia G. Priori, Dieter Naber, Per Tanghøj, Joseph Peuskens
Publikováno v:
European Neuropsychopharmacology. 20:829-838
The incidence of suicide attempts (fatal and non-fatal) was analysed in a prospective cohort of patients with schizophrenia randomly assigned to sertindole (4905 patients) or risperidone (4904 patients) in a parallel-group open-label study with blind
Publikováno v:
European Archives of Psychiatry and Clinical Neuroscience. 261:231-239
The presence of the metabolic syndrome is an important risk factor for cardiovascular disease and diabetes. The short- and long-term metabolic safety of sertindole was compared to that of risperidone in a subset of patients enrolled in the sertindole
Autor:
Joseph Peuskens, R. D. Mann, Gillian C. Hall, Brian Everitt, Marc-Antoine Crocq, Florence Thibaut, C. Le Jeunne, Mondher Toumi, Malcolm Lader, Nicholas Moore, Shl Thomas, Aurélia Mittoux, Silvia G. Priori, Miriam C. J. M. Sturkenboom, Milou Daniel Drici, Dieter Naber, Per Tanghøj
Publikováno v:
Acta Psychiatrica Scandinavica. 122:345-355
Thomas SHL, Drici MD, Hall GC, Crocq MA, Everitt B, Lader MH, Le Jeunne C, Naber D, Priori S, Sturkenboom M, Thibaut F, Peuskens J, Mittoux A, Tanghoj P, Toumi M, Moore ND, Mann RD. Safety of sertindole versus risperidone in schizophrenia: principal
Publikováno v:
The primary care companion for CNS disorders. 18(5)
Background Brexpiprazole is a serotonin-dopamine activity modulator. We evaluated the effects of adjunctive treatment with brexpiprazole on sleep disturbances in patients with DSM-IV-TR major depressive disorder (MDD) and inadequate response to antid
Publikováno v:
Pharmacoepidemiology and Drug Safety.
Purpose To explore whether the presence of specific health services impact the time to death in schizophrenia. Methods Cox's proportional hazard model was used to assess the effect of country-specific health care variables (total health care expendit
Publikováno v:
International clinical psychopharmacology. 27(6)
The aim of this study was to evaluate the efficacy, safety, and tolerability of sertindole in comparison with olanzapine in patients with chronic schizophrenia who did not respond successfully to their previous treatments. Patients with schizophrenia
Publikováno v:
Schizophrenia Research. 123:276-277